NSB Research
New Smyrna Beach, Florida, United States
Medical clinic in Edgewater, Florida
1410 S Ridgewood Ave, Edgewater, FL 32132
About NSB Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
5
Pfizer
4
Arena Pharmaceuticals
2
ModernaTX, Inc.
2
Boehringer Ingelheim
1
MediBeacon
1
Milestone Pharmaceuticals Inc.
1
Phathom Pharmaceuticals, Inc.
1
Seqirus
1
Shanghai Pharma Biotherapeutics USA Inc.
1
Clinical Trials at NSB Research
During the past decade, NSB Research conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 6 clinical trials were completed, i.e. on
average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2013-10-01
2016-04-01
Completed
711
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
2015-06-17
2020-06-17
Completed
1,012
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
2015-12-02
2025-02-27
Active, not recruiting
878
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
2018-02-27
2024-06-28
Recruiting
600
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2018-06-27
2025-06-24
Recruiting
485
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
2018-08-24
2029-12-27
Recruiting
1,200
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
2018-12-10
2020-11-13
Terminated
169
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "NSB Research" #1 sponsor was "Celgene" with 5 trials, followed by "Pfizer" with 4 trials
sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "ModernaTX, Inc." with 2 trials sponsored and "Boehringer Ingelheim"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NSB Research"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at NSB Research
According to Clinical.Site data, the most researched conditions in "NSB Research" are
"Ulcerative Colitis" (7 trials), "Crohn Disease" (3 trials), "Atrial Fibrillation" (1 trials), "Chronic Kidney Disease" (1 trials) and "Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps" (1 trials). Many other conditions were trialed in "NSB Research" in a lesser frequency.
Clinical Trials Intervention Types at NSB Research
Most popular intervention types in "NSB Research" are "Drug" (16 trials), "Other" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Etrasimod" (4 trials), "Ozanimod" (3 trials), "RPC1063" (2 trials) and "Active Comparator: Licensed IIV IIV will be administered as a single dose intramuscularly on Day 1" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NSB Research
The vast majority of trials in "NSB Research" are
18 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at NSB Research
Currently, there are NaN active trials in "NSB Research".
undefined are not yet recruiting,
9 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in NSB Research,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in NSB Research, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".